Accel Research Sites - Maitland

Maitland, Florida 32751-7258

1 studies enrolling now · 10 studies all time

What they study most

Attention Deficit/Hyperactivity Disorder, COVID-19, Depression, Depression - Major Depressive Disorder, Depression Disorder, Depression Disorders, Depression in Adults, Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy, Influenza, Major Depressive Disorder (MDD), Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Studies at this site

• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder — Recruiting now
• A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection — Running, not enrolling
• A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Completed
• Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) — Running, not enrolling
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD — Completed
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age — Completed
• Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) — Completed
• An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD — Completed
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments — Completed